The Supreme Court keeps abortion pill mifepristone available by telehealth
NPR • • general
Key Points:
- The Supreme Court has maintained the status quo on medication abortion access by staying a 5th Circuit Court ruling that would have banned mailing the abortion pill mifepristone nationwide, allowing telehealth prescriptions to continue during ongoing lower court proceedings.
- Justices Samuel Alito and Clarence Thomas dissented, with Alito criticizing the order as undermining the Dobbs decision that returned abortion regulation to individual states.
- Telehealth abortion involves remote consultation and prescription of mifepristone and misoprostol, a method that has increased abortion access and accounts for about one quarter of U.S. abortions since Roe v. Wade was overturned.
- Nearly two dozen Democratic-led states and various experts defended FDA's approval and regulation of mifepristone, warning that the appeals court ruling threatens the agency’s science-based drug approval system, while Republican-led states supported Louisiana's challenge.
- Notably, the FDA did not submit a brief to the Supreme Court in this case, reflecting political complexities and hesitancy within the Trump administration regarding abortion policy enforcement.